(Reuters) – British researchers have identified the level of antibody protection needed to prevent symptomatic COVID-19, the University of Oxford said on Thursday, adding that results from the study could help speed up new vaccine development.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shinjini Ganguli)
